Adenovirus-mediated apo(a)-antisense-RNA expression efficiently inhibits apo(a) synthesis in vitro and in vivo

Gene Therapy
S FrankG M Kostner

Abstract

Apo(a) is a very atherogenic plasma protein without apparent function, which is highly expressed in humans. The variation in plasma Lp(a) concentration among individuals is considerable. Approximately 10-15% of the white population exhibit plasma Lp(a) concentrations above the atherogenic cut-off value of approximately 30 mg/dl. Since there is currently no safe way of treating those patients with drugs, we have tested the possibility of interfering with apo(a) biosynthesis by adenovirus-mediated expression of antisense apo(a) mRNA comprising the 5' UTR, the signal sequence and the first three kringles of native apo(a). Transduction of rat hepatoma McA RH 7777 cells which stably expressed apo(a) with 18 kringle IV (KIV) domains with apo(a)-antisense adenovirus (AS-Ad) at multiplicity of infection (MOI) of 30 reduced apo(a) synthesis to 23% as compared with control cells. As apo(a) is not synthesized in laboratory animals, we induced biosynthesis of the N-terminal fragments of apo(a) in mice by adenovirus-mediated gene transfer. Cotransduction of these mice with AS-Ad, which expressed up to eight times higher amounts of apo(a) than stable transgenic apo(a) mice, led to an almost complete disappearance of apo(a) from plasma. We co...Continue Reading

References

Apr 1, 1973·Virology·F L Graham, A J van der Eb
Oct 1, 1982·Cell·H D Robertson
Jan 1, 1981·Atherosclerosis·G M KostnerG B Qunici
Sep 1, 1995·The Journal of Clinical Investigation·M J CallowE M Rubin
Nov 15, 1994·The Biochemical Journal·S FrankG M Kostner
Jul 1, 1993·Human Molecular Genetics·C LacknerH H Hobbs
Jun 15, 1996·Nucleic Acids Research·G Rotondo, D Frendewey
Dec 6, 1996·The Journal of Biological Chemistry·R M LawnD J Grainger
Mar 1, 1997·Protein Engineering·S Frank, G M Kostner

❮ Previous
Next ❯

Citations

Jul 26, 2012·Molecular Therapy : the Journal of the American Society of Gene Therapy·H Steve ZhangFrank J Giordano
Aug 2, 2002·Current Opinion in Lipidology·Karam M Kostner, Gerhard M Kostner
Aug 2, 2011·The Journal of Clinical Investigation·Indumathi ChennamsettyGert M Kostner
Jul 30, 2005·Expert Opinion on Biological Therapy·Uli C Broedl, Daniel J Rader
Oct 9, 2012·Metabolism: Clinical and Experimental·Jane Hoover-Plow, Menggui Huang
Nov 9, 2016·Journal of Lipid Research·Karam M Kostner, Gert M Kostner
Dec 26, 2001·The Journal of Immunology : Official Journal of the American Association of Immunologists·Stefan WirtzMarkus F Neurath

❮ Previous
Next ❯

Related Concepts

Related Feeds

CREs: Gene & Cell Therapy

Gene and cell therapy advances have shown promising outcomes for several diseases. The role of cis-regulatory elements (CREs) is crucial in the design of gene therapy vectors. Here is the latest research on CREs in gene and cell therapy.